PROMETIC LIFE SCIENCES — prometic.com
Prometic is a biopharmaceutical corporation with globally recognized expertise in bioseparation and uses its own affinity technology for the development of best in class plasma-derived therapeutics and orphan drugs. Prometic is also active in developing its own novel small molecule therapeutics products targeting unmet medical needs in the field of fibrosis. Headquartered in Laval, Canada, Prometic has a global presence through its various sites in the UK and USA, providing both manufacturing and R&D capability. These strategic locations facilitate Prometic’s growth globally and supports all business activity in American, European and Asian markets.
Prometic has developed core competencies in strategic fields, including:
- Purification of biologics
- Drug development
- Proteomics
- Elimination of pathogens
The business is now focused on developing its range of therapeutics from both its plasma-derived and small-molecule platform.
Prometic is publicly traded on TSX (Symbol: PLI) and OTCQX (Symbol: PFSCF).
______________________________________________________________________________________
LINK: PROMETIC THERAPEUTICS
______________________________________________________________________________________
LINK: PROMETIC PRESS RELEASES
______________________________________________________________________________________
WELCOME! —This is a moderated board. No spam, ad hominem attacks or flaming. One warning.
______________________________________________________________________________________
|
